02575.HK
Xuanzhubio-b
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 8.60
+0.64%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.59x
- Price / sales
- 33.14x
- Price / cash flow
- -18.14x
Enterprise value
- Enterprise value
- HKD 3.3B
- EV / sales
- 28.12x
- EV / EBITDA
- -17.71x
- EV / EBIT
- -15.43x
- Market cap
- HKD 3.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026